As shown in Table 1, SLC16A1 overexpression was more prevalent in female patients in ACC, KICH, and KIRP, and that Caucasians had a higher proportion of SLC16A1 overexpression than other races in BLCA. This evidence concerns the gene SLC16A1 and bladder transitional cell carcinoma.